Amdocs Reports Q4 2024 Financial Results

Ticker: DOX · Form: 6-K · Filed: Nov 13, 2024 · CIK: 1062579

Amdocs LTD 6-K Filing Summary
FieldDetail
CompanyAmdocs LTD (DOX)
Form Type6-K
Filed DateNov 13, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: earnings, financial-results

TL;DR

Amdocs dropped its Q4 earnings report on Nov 12th - check the exhibits for the deets.

AI Summary

On November 12, 2024, Amdocs Limited announced its financial results for the quarter ended September 30, 2024. The company issued a press release and accompanying presentation detailing these results, which are furnished as exhibits to this Form 6-K filing.

Why It Matters

This filing provides investors with the latest financial performance data for Amdocs, crucial for understanding the company's current health and future prospects.

Risk Assessment

Risk Level: low — This is a routine financial results disclosure, not indicating any new or unusual risks.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

The primary purpose is to announce Amdocs Limited's financial results for the quarter ended September 30, 2024, via a press release and accompanying presentation.

When did Amdocs Limited issue the press release announcing these financial results?

Amdocs Limited issued the press release on November 12, 2024.

Which exhibits are furnished with this Form 6-K?

Exhibits 99.1 (the press release) and 99.2 (the accompanying presentation) are furnished with this Form 6-K.

What fiscal period do the announced financial results cover?

The financial results announced cover the quarter ended September 30, 2024.

Is Amdocs Limited required to file annual reports under Form 20-F or Form 40-F?

Yes, Amdocs Limited files annual reports under cover of Form 20-F, as indicated by the checkmark next to FORM 20-F.

Filing Stats: 277 words · 1 min read · ~1 pages · Grade level 9.7 · Accepted 2024-11-12 19:25:03

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AMDOCS LIMITED By: /s/ Matthew E. Smith Matthew E. Smith Secretary and Authorized Signatory Date: November 12, 2024

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing